Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Commentary

Extending international sepsis epidemiology: the impact of organ dysfunction

Annette M Esper email and Greg S Martin email

Division of Pulmonary, Allergy and Critical Care, Emory University School of Medicine, 49 Jesse Hill Jr Drive [FOB], Atlanta, GA 30303, USA

author email corresponding author email

Critical Care 2009, 13:120doi:10.1186/cc7704

Published: 23 February 2009


See related research by Blanco et al., http://ccforum.com/content/12/6/R158

Abstract

In the previous issue of Critical Care, Blanco and colleagues contributed to a growing body of literature on the international epidemiology of severe sepsis. Taken together, these studies confirm that the sepsis incidence is high, that the development of organ dysfunction is a major determinant of mortality and that the occurrence of organ dysfunction is influenced by chronic comorbid medical conditions. It is clear that early detection of organ dysfunction and serial sequential organ dysfunction scoring provides us with the best chance to optimize clinical care. Identifying factors that contribute to the development of organ dysfunction in sepsis will lead to the development of new treatment modalities that will reduce mortality. Future studies must therefore focus on the impact of new treatment modalities for preventing progression to multiple organ dysfunction syndrome and consequent mortality in sepsis.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.